| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |